Research interests
Listed grant project: Micra Rate Response, awarded by Medtronic, Inc.[3]
2018 to 2019
Camille Genise Frazier is a Duke University Professor of Medicine and a leader in cardiovascular education, serving as Associate Program Director for the Cardiovascular Disease Fellowship. She earned her M.D. from Case Western Reserve University in 1999, completed Duke medicine residency training from 1999 to 2002, and pursued a Duke cardiology fellowship from 2002 to 2003. Her documented scholarship spans electrophysiology, leadless and conduction-system pacing, remote device-clinic care, implantable cardioverter-defibrillators, atrial fibrillation, dysautonomia, and sex-based cardiovascular outcomes. She has also taught on exercise for POTS and dysautonomia, including a 2016 conference lecture. In a 2024 faculty statement, she described developing leadership programs for Black electrophysiologists and reported having been at Duke for 25 years at that time.
Reported having been at Duke for 25 years at the time of the statement
Each topic is linked to its supporting source in Sources.
Training includes Provided a lecture on exercise as a treatment tool for POTS and other forms of dysautonomia at Dysautonomia International's 2016 annual conference, Participation in the Autonomic Testing & Postural Orthostatic Tachycardia Syndrome Management CME course, Cardiology fellowship at Duke University, and Medical residency at Duke University in Medicine, plus 11 more records.
Explore education and trainingAs of 2016
As of 2015
As of 2003
As of 2002
As of 1999
Listed grant project: Micra Rate Response, awarded by Medtronic, Inc.[3]
2018 to 2019
Listed grant project: MICRA Trans-Catheter, awarded by Medtronic, Inc.[3]
2018 to 2024
Listed grant project: NAVIGATE X4, awarded by Boston Scientific Corporation.[3]
2014 to 2021
Listed grant project: Product Surveillance Registry (PSR), awarded by Medtronic, Inc.[3]
2015 to 2026
Listed grant project: Wrap-it, awarded by Medtronic, Inc.[3]
2015 to 2020
Publication: “2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic.”[3]
2023
Publication: “Alert-based remote monitoring: A model for increased reimbursement to meet device clinic workload while achieving overall health system cost savings.”[3]
2024
Publication: “Association of leadless pacing with ventricular and valvular function.”[3]
2023
Publication: “Bedside IVC Echocardiography to Distinguish Autonomic Dysfunction-Predominant Orthostasis From Right Ventricular Failure in Patients With LVADs.”[3]
2026
Publication: “Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study.”[3]
2023
Publication: “Current Landscape of Compression Products for Treatment of Postural Orthostatic Tachycardia Syndrome and Neurogenic Orthostatic Hypotension.”[3]
2024
Publication: “Design of a post-market registry for the extravascular implantable cardioverter-defibrillator: The Enlighten Study.”[3]
2025
Publication: “Enhancing patient acceptance of ICD implantation through structured shared decision making: conversation is key.”[3]
2024
Publication: “Sex-Based Differences in Left Bundle Branch Capture During Left Bundle Branch Area Pacing.”[3]
2026
Publication: “Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center Experience.”[3]
2025